Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             40 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney Care Correa-Rotter, Ricardo

42 2 p. 559-567
artikel
2 Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data Young, Corinne

42 2 p. 830-848
artikel
3 An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases Yang, Min

42 2 p. 568-578
artikel
4 An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma Ndirangu, Kerigo

42 2 p. 977-994
artikel
5 A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan Nakagawa, Naoto

42 2 p. 772-787
artikel
6 Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain Ballesteros-Pomar, María Dolores

42 2 p. 1265-1282
artikel
7 Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry Lugogo, Njira L.

42 2 p. 849-862
artikel
8 CKD-Associated Pruritus is Associated with Greater Use of Antidepressants and Anti-pruritus Medications Ion Titapiccolo, Jasmine

42 2 p. 1283-1289
artikel
9 Clinical Features and Current Pharmacotherapy of OAB in Practice: Ideal and Reality Tsubouchi, Kazuna

42 2 p. 1094-1107
artikel
10 Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease Mannino, David

42 2 p. 1131-1146
artikel
11 Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors Mease, Philip J.

42 2 p. 734-751
artikel
12 Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease McCarrier, Kelly P.

42 2 p. 935-976
artikel
13 Correction to: Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years Torres Pradilla, Mauricio

42 2 p. 1290
artikel
14 Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis Earla, Jagadeswara R.

42 2 p. 886-903
artikel
15 Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective Igarashi, Ataru

42 2 p. 995-1008
artikel
16 Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry Heffler, Enrico

42 2 p. 1196-1206
artikel
17 Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice Mignani, Renzo

42 2 p. 597-635
artikel
18 Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial Singh, Awadhesh Kumar

42 2 p. 801-812
artikel
19 Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review Büsch, Katharina

42 2 p. 752-771
artikel
20 Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis Rudofsky, Gottfried

42 2 p. 788-800
artikel
21 Healthcare Utilization, Costs, and Treatment Discontinuation in Adults with Episodic Migraine Initiating Galcanezumab Versus Rimegepant: A US Retrospective Claims Analysis Kim, Gilwan

42 2 p. 918-934
artikel
22 Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review Azimpour, Khashayar

42 2 p. 579-596
artikel
23 Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals Spinner, Christoph D.

42 2 p. 666-719
artikel
24 Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study Hu, Ying

42 2 p. 904-917
artikel
25 Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management Nie, Shanshan

42 2 p. 636-665
artikel
26 Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Baptist, Alan P.

42 2 p. 1061-1074
artikel
27 One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis Calzavara-Pinton, Piergiacomo

42 2 p. 720-733
artikel
28 Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers Wang, Xiaodong

42 2 p. 813-829
artikel
29 Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome Darwish, Mona

42 2 p. 1026-1043
artikel
30 Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2–4 Years with Rett Syndrome Darwish, Mona

42 2 p. 1009-1025
artikel
31 Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United Kingdom Drahos, Jennifer

42 2 p. 863-885
artikel
32 Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19 Dreher, Michael

42 2 p. 1237-1250
artikel
33 Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia Li, Pengxiang

42 2 p. 1251-1264
artikel
34 Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Inoue, Yoshikazu

42 2 p. 1075-1093
artikel
35 Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies Kagan, Risa

42 2 p. 1147-1164
artikel
36 Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice Daskalopoulou, Stella S.

42 2 p. 1108-1130
artikel
37 The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn’s Disease Dubinsky, Marla

42 2 p. 1044-1060
artikel
38 Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study Lam, Ka-On

42 2 p. 1222-1236
artikel
39 Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database Luthra, Rakesh

42 2 p. 1165-1195
artikel
40 US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review Eugeni, Patrick

42 2 p. 1207-1221
artikel
                             40 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland